Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for China Pharma Holdings (CPHI) over the last 16 years, with Q3 2025 value amounting to -$92.4.

  • China Pharma Holdings' Times Interest Earned rose 4173.7% to -$92.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.08, marking a year-over-year decrease of 70413.68%. This contributed to the annual value of -$167.76 for FY2024, which is 8638.21% down from last year.
  • Per China Pharma Holdings' latest filing, its Times Interest Earned stood at -$92.4 for Q3 2025, which was up 4173.7% from -$96.2 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Times Interest Earned peaked at $4.69 during Q4 2023, and registered a low of -$203.08 during Q2 2024.
  • Its 5-year average for Times Interest Earned is -$55.42, with a median of -$10.77 in 2023.
  • Per our database at Business Quant, China Pharma Holdings' Times Interest Earned skyrocketed by 13855.13% in 2023 and then crashed by 602676.97% in 2024.
  • China Pharma Holdings' Times Interest Earned (Quarter) stood at -$1.95 in 2021, then tumbled by 524.8% to -$12.16 in 2022, then soared by 138.55% to $4.69 in 2023, then crashed by 3852.42% to -$175.84 in 2024, then skyrocketed by 47.45% to -$92.4 in 2025.
  • Its Times Interest Earned stands at -$92.4 for Q3 2025, versus -$96.2 for Q2 2025 and -$111.78 for Q1 2025.